Usefulness of nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study)
- 1 January 2001
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 87 (1), 28-33
- https://doi.org/10.1016/s0002-9149(00)01267-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Possible uses of gene therapy in reducing coronary restenosisHeart, 1997
- A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplastyThe American Journal of Cardiology, 1994
- Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis.Heart, 1994
- Intra- and interobserver variability of a fast on-line quantitative coronary angiographic systemThe International Journal of Cardiovascular Imaging, 1993
- Restenosis revisited: Insights provided by quantitative coronary angiographyAmerican Heart Journal, 1993
- Calcium antagonists differently inhibit proliferation of human coronary smooth muscle cells in response to pulsatile stretch and platelet-derived growth factor.Circulation, 1993
- Effects of diltiazem on complications and restenosis after coronary angioplastyThe American Journal of Cardiology, 1991
- Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.Circulation, 1988
- Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplastyJournal of the American College of Cardiology, 1986
- Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1985